Immunotherapy effective against rare subtype of advanced melanoma
Immunotherapy drug pembrolizumab effectively shrinks or eliminates tumors in nearly 90% of patients with advanced desmoplastic melanoma, according to a clinical trial published in Nature Medicine and reported by UCLA. … Read More